Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Eliem Therapeutics, Inc - Common Stock
(NQ:
ELYM
)
5.110
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Oct 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Eliem Therapeutics, Inc - Common Stock
Eliem Therapeutics Announces Rebranding and Corporate Name Change to Climb Bio, Inc.
October 02, 2024
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit
September 11, 2024
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Eliem Therapeutics Announces Additions to its Leadership Team
August 26, 2024
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Eliem Therapeutics Reports Second Quarter Financial Results
August 14, 2024
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Eliem Therapeutics Announces its Addition to the Russell 2000® and Russell 3000® Indexes
June 28, 2024
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
June 27, 2024
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
ELYM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Eliem Therapeutics, Inc. Is Fair to Shareholders
April 11, 2024
From
Halper Sadeh LLC
Via
Business Wire
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
April 11, 2024
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Eliem Therapeutics Announces Plans to Explore Strategic Alternatives
July 20, 2023
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Eliem Therapeutics Reports First Quarter Financial Results and Business Highlights
May 11, 2023
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Eliem Therapeutics Reports Fourth Quarter and Year-End Financial Results and Business Highlights
March 06, 2023
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Eliem Therapeutics Provides Strategic Update and Announces Leadership Transition
February 09, 2023
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Eliem Therapeutics at the 5th Annual Evercore ISI HealthCONx Virtual Conference
November 30, 2022
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Eliem Therapeutics Reports Third Quarter Financial and Business Highlights
November 14, 2022
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Eliem Therapeutics to Participate at Two Upcoming Investor Conferences
November 08, 2022
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Eliem Therapeutics Provides Update on Pipeline Progress
October 05, 2022
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
